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OBJECTIVES: The objective was to develop the Self-Injection
Assessment Questionnaire© (SIAQ© Version 1) as a comprehen-
sive instrument for use across diseases to assess the perceived
advantages of self-injection (SI) and the potential limitations of
SI—speciﬁcally, psychological, social or physical limitations.
METHODS: The SIAQ© was developed following four steps: 1)
in-depth face-to-face interviews involving focus groups with
rheumatoid arthritis or Crohn’s disease (two conditions charac-
terised by different symptoms and physical limitations); 2) quali-
tative analysis and development of a conceptual model to
illustrate the domains relevant to patients; 3) questionnaire item
generation in US English using patients’ verbatim; and 4) cogni-
tive debrieﬁng interviews to evaluate content validity. RESULTS:
Perceived advantages of SI were: convenient treatment schedul-
ing, feeling in control of the disease, few side-effects and high
efﬁcacy of the medication. In addition, some patients expressed
psychological limitations (fear of needles, fear of pain, fear of
self-injecting, lack of self-conﬁdence in performing injections
properly), physical limitations (device handling problems), social
limitations (embarrassed ‘to use needles’), and storage problems.
Thirty-three items were generated and tested during cognitive
debrieﬁng interviews. The ﬁnal questionnaire (SIAQ© Version 1)
is composed of 23 items grouped into six domains, which assess
psychological limitations about injections in general; psychoso-
cial limitations about SI in particular; physical limitations about
pain and skin reactions; physical limitations about the usability
of the SI device; convenience and satisfaction with SI; and will-
ingness to continue SI. CONCLUSION: The SIAQ© can be used
to assess the perceived advantages of SI (convenience and satis-
faction) and the potential limitations of SI—speciﬁcally, psycho-
logical (fear of injections), social (acceptability) or physical
aspects (usability and injection-site reactions such as pain) and
willingness to continue SI in the future. The psychometric prop-
erties of the SIAQ© will be evaluated in clinical studies.
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OBJECTIVES: Health Care Systems consists of a large number
of characteristics. However the scarcity of resources restricts the
implementation of some policies although they would certainly
contribute to improve the population health. This implies that
improvement in a particular domain of the health care system
leads to some sacriﬁces in other areas. Then, the public is asked
to weigh the feature of the Health Care System and make-trade
offs between attributes they consider important. For instance
how much additional tax the public is prepared to accept for a
decrease in waiting times for surgery. This study intends to use
the Discrete Choice Experiment to assess the beneﬁts in these
characteristics. METHODS: The different attributes of the
Health Care System are identiﬁed using a literature search. This
serves as a basis for the construction of a binary outcome ques-
tionnaire across 27 pairwise choices. A sample of 50 persons was
interviewed in the area surrounding York University. The logit
model has been used for the analysis, which assesses the public’s
preference towards different attributes. RESULTS: The outcomes
were in line with prior expectations. There was internal con-
stancy in the result and those were statically signiﬁcant. A main
factor for the public’s valuation was the number of people who
would miss out on treatment due to cost. They were also much
more concerned about the Infant mortality than Life expectancy.
Furthermore the willingness to pay was estimated for each
attribute. CONCLUSION: This experiment has demonstrated
that the Discrete Choice Experiment could inform the decision
makers about the public’s preferences for attributes within the
Health care System. Further, it will allow health care decision
makers to more accurately compare the performance of different
countries, accounting for the individual preferences of each
population.
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OBJECTIVES: Utility index are a basic tool to calculate the
“Quality Adjusted Life Years-QALYs” and the derived value of
cost per QALY. At present there are some models used to calcu-
late these measures from preference studies. Some of them, as it
is the EQ-5D, include a dummy variable which could enlarge the
utility index value when score in all its dimensions are the best
possible. So, validity of those tools may be affected. The aim of
present study is to analyze the validity of Spanish version of the
EQ-5D as an assessment instrument of preferences. METHODS:
Various simulations were carried out with different samples
which had the same mean value in the EQ-5D tariff, but different
percentage of subjects who achieved the best score (1 point) after
an intervention. It was understood that the intervention pro-
duced an improvement of 1 point in one of the EQ-5D dimen-
sions, and that beneﬁt was present in all subjects. RESULTS:
Different samples obtained different values in the EQ-5D after
intervention depending on the percentage of subjects who
achieved the best value in all the EQ-5D dimensions. Maximum
differences were of 0.15 points, which is a value higher than that
considered clinically relevant for the EQ-5D. CONCLUSION:
An improvement in an utility index associated to an intervention
could depend on the characteristics of the studied sample and this
do not seem adequate or desirable. Although an intervention is
equally effective in various samples, the results are not the same
and this could be a serious handicap for the utility index.
Other methods to calculate utility index values must be devel-
oped in order to better evaluate the changes associated to an
intervention.
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OBJECTIVES: A new Computer Adaptive Testing (CAT-Health)
for evaluating the generic Health-Related Quality of Life-
HRQoL was recently developed in our country. The purpose of
the present work was to validate the CAT-Health in a sample of
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